47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0 | 0,1 | 97,1 |
Gross profit (loss) | 0,2 | 0,1 | 0,1 | 25,5 |
EBITDA | 0,2 | 0,1 | 0,1 | 42,1 |
Short time liabilities | 1,2 | 1,3 | 1,3 | -1,3 |
Other operating costs | 0 | -0 | 0 | 232,1 |
Equity capital | 0,4 | 0,5 | 0,6 | 19 |
Operating profit (EBIT) | 0,2 | 0,1 | 0,1 | 25,1 |
Assets | 1,6 | 1,8 | 1,8 | 4,1 |
Net profit (loss) | 0,2 | 0,1 | 0,1 | 25,5 |
Cash | 0,6 | 0,8 | 0,4 | -56,2 |
Net income from sale | 5,7 | 6,3 | 7,2 | 14 |
Liabilities and provisions for liabilities | 1,2 | 1,3 | 1,3 | -1,3 |
Working assets | 1,6 | 1,7 | 1,8 | 4,7 |
Other income costs | 0 | 0 | 0 | 392,9 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 43,5 | 12,4 | 13,1 | 0,7 |
Equity capital to total assets | 25,7 | 26,7 | 30,5 | 3,8 |
Gross profit margin | 3,2 | 0,9 | 1 | 0,1 |
EBITDA Margin | 3,2 | 0,9 | 1,2 | 0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 76 | 75 | 65 | -10 |
Current financial liquidity indicator | 1.3383790254592896 | 1.3562992811203003 | 1.4389150142669678 | 0 |
Net dept to EBITDA | -3.5942559242248535 | -13.995327949523926 | -4.315435409545898 | 9,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane